ORG Partners’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$130K Buy
+1,066
New +$122K 0.02% 403
2025
Q1
Sell
-70
Closed -$6.31K 1613
2024
Q4
$6.31K Hold
70
﹤0.01% 977
2024
Q3
$6.93K Sell
70
-361
-84% -$35.5K ﹤0.01% 844
2024
Q2
$40.1K Buy
+431
New +$38.6K 0.01% 865
2023
Q3
Sell
-302
Closed -$25K 1615
2023
Q2
$25K Buy
+302
New +$25.3K ﹤0.01% 824

Other funds holding XBI

ORG Partners's XBI Position: Q4 2025 in Review

ORG Partners opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q4 2025: 1,066 shares worth $130K. The stake represents 0.02% of the portfolio and ranks #403 among its holdings. This is a return to the name: ORG Partners previously reported a position in XBI as recently as Q4 2024.

ORG Partners first reported a position in XBI in Q2 2023 and has held it in 5 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q4 2025.

  • ORG Partners held 1,066 shares of State Street SPDR S&P Biotech ETF worth $130K as of Q4 2025.
  • State Street SPDR S&P Biotech ETF was a new ORG Partners position in Q4 2025.
  • State Street SPDR S&P Biotech ETF made up 0.02% of ORG Partners's portfolio in Q4 2025, its #403 holding.
  • ORG Partners first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 5 quarters since.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2025.

Based on ORG Partners's 13F filing for Q4 2025, filed 14 Jan 2026.